- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US55.5300 USD 5.3200 10.60%
As of 21:10:00 ET on 03/07/2014.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic desease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc C BeerChairman/CEO||Mark J FitzpatrickChief Financial Officer|
|Mark SumerayChief Medical Officer||Martha J CarterChief Regulatory Officer|
|Craig FraserPresident: US Commercial||Anne Marie CookSenior VP/Secretary/Gen Cnsl|